Fate Therapeutics, Inc.FATENASDAQ
Loading
Debt to Assets Over TimeElevated
Percentile Rank71
3Y CAGR+16.4%
5Y CAGR+9.3%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
+16.4%/yr
vs +22.0%/yr prior
5Y CAGR
+9.3%/yr
Recent acceleration
Acceleration
-5.7pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.24 | +26.2% |
| 2024 | 0.19 | -5.4% |
| 2023 | 0.20 | +32.0% |
| 2022 | 0.15 | +24.4% |
| 2021 | 0.12 | -20.3% |
| 2020 | 0.16 | +75.5% |
| 2019 | 0.09 | +27.5% |
| 2018 | 0.07 | -50.3% |
| 2017 | 0.14 | +25.1% |
| 2016 | 0.11 | - |